Cytodyn
Biotechnology company focused on the development of new therapies to combat infections with immune deficiency viruses.
Launch date
Employees
Market cap
€166m
Enterprise valuation
€190m (Public information from Sep 2024)
Share price
$0.16 CYDY
Lake Oswego Oregon (HQ)
Authorizing premium user...